Bristol Myers Squibb has announced that the FDA has given approval to label updates for Breyanzi and Abecma to treat multiple ...

The collaboration, set to begin on 1 July, will see Novo Nordisk team up with the telehealth company to offer Wegovy to ...

Porton Advanced Solutions and EVA Pharma have signed an MoU to enhance the development capabilities for CAR T-cell therapies.

AI has been a buzzword in the pharmaceutical industry for almost a decade, with countless headlines promising to ...

Equipped with a new CEO, Vor Bio is transitioning into an autoimmune player, leaving cell and gene therapy behind.

Scientific experts are concerned about what role vaccines will play in US public health strategy under the Trump ...

While the UK continues its close 25-year partnership with Gavi, the US is halting funding to the organisation. In a move that ...

The CDE of China's NMPA has granted BioCity's endothelin receptor type A (ETA) antagonist, SC0062, a second BTD.

Oligonucleotides could become a transformative treatment for a range of serious health conditions, but scaling up production is a persistent challenge. A new specialist manufacturing facility in ...

The US FDA has granted approval for a label update to Eli Lilly and Company's Amyvid (florbetapir F 18 injection) for use ...

I’m in London, and I just paid for this damn fat drug I take. I said, it’s not working. They said, he said, I just paid $88 ...

Kymera’s programme focuses on removing CDK2 from cells compared to other therapies that target the protein’s inhibition.